North America Microelectrode Array In Vitro Market Report 2021-2031 by Scope, Segmentation, Dynamics, and Competitive Analysis

Description

List of Tables

The North America microelectrode array in vitro market was valued at approximately US$ 8.44 million in 2023 and is projected to grow to US$ 11.94 million by 2031, reflecting a compound annual growth rate (CAGR) of 4.4% during this period.

Increasing Demand in Neuroscience Research

The rising demand for microelectrode arrays (MEAs) in neuroscience research is a significant driver of the North American market. These arrays are essential for testing new pharmaceuticals on neuronal cultures, allowing researchers to evaluate the impact of drugs on neural activity and develop targeted therapies. In vitro models are utilized to study a range of neurological and neuropsychiatric disorders, including Alzheimer's disease, Parkinson's disease, epilepsy, and various neurodevelopmental conditions. The growing prevalence of these disorders has led to an increased need for microelectrode array systems, which facilitate the examination of cellular and molecular changes associated with these diseases and their effects on neural functions.

By employing microelectrode arrays in in vitro cell models, researchers can measure neural activity and assess how drug compounds can modulate this activity, restore normal network function, or counteract disease-related abnormalities. This capability is crucial for identifying promising drug candidates early in the development process. As neuroscience research continues to expand, companies like Axion BioSystems, Multi Channel Systems, and MaxWell Biosystems are innovating and launching new products to meet this demand. For example, in April 2024, Axion BioSystems introduced the Maestro Volt, a cost-effective benchtop microelectrode array system designed for academic laboratories with lower throughput requirements. This 6-well device is suitable for both neurological and cardiovascular research, featuring user-friendly controls and high-quality standards associated with the Maestro brand.

North America Market Overview

Investors are increasingly interested in companies that manufacture high-throughput microelectrode arrays for in vitro research, which are essential for research institutions, pharmaceutical companies, and the biotechnology sector. Innovations in CMOS-based microelectrode arrays, stem cell research, neuroprosthetics, and in vitro toxicology testing are propelling the demand for these technologies. Notably, in June 2020, the Georgia State University Research Foundation received US$ 197.56 million from the US National Science Foundation to develop microelectrode array sensors for SARS-CoV-2 and other RNA viruses, showcasing the potential of these technologies to address global health challenges.

The US Environmental Protection Agency has also recognized microelectrode arrays as valuable tools for conducting in vitro toxicity tests, particularly for assessing developmental neurotoxicity, which poses significant challenges in the approval of new chemicals and drugs. Such regulatory support has led to increased use of microelectrode arrays for high-throughput screening in drug discovery and disease modeling, as researchers seek reliable platforms for real-time monitoring of cellular and tissue activity.

The adoption of microelectrode arrays in innovative in vitro models, such as organoids, has spurred the development of advanced technologies, including 3D microelectrode array technology and high-density CMOS-based microelectrode arrays. For instance, in January 2023, BMSEED, a US-based provider of microelectrode array technologies, filed a patent application for its 2D stretchable microelectrode array (sMEA) that has been enhanced into a 3D version, allowing for electrophysiological measurements from brain organoids and 3D tissue cultures, particularly in Alzheimer's research. This 3D-sMEA technology features adjustable pockets with embedded electrodes that conform to organoids, enabling researchers to capture neural signals from approximately 80% of the surface area of intact organoids.

Market Segmentation

The North America microelectrode array in vitro market is segmented by product, application, and country. In terms of product, the market is divided into classical MEA, multiwell-MEA, and CMOS-MEA, with the multiwell-MEA segment holding the largest market share in 2023. Regarding application, the market is categorized into cardiomyocytes, nerve, and others, with the cardiomyocytes segment also leading in market share. By country, the market is segmented into the US, Canada, and Mexico, with the US dominating the market in 2023.

Key Players

Leading companies in the North America microelectrode array in vitro market include Tucker Davis Technologies, SCREEN Holdings Co., Ltd., Plexon Inc., MaxWell Biosystems AG, Harvard Bioscience Inc., Axion BioSystems Inc., 3Brain AG, NeuroNexus Technologies Inc., MicroElectrodeDevices, Blackrock Microsystems, Inc., NMI Technologietransfer GmbH, and BMSEED. These companies are at the forefront of developing innovative solutions to meet the growing demands of neuroscience and related fields.

Product Code: BMIRE00032080

1. Introduction

1.1 Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macroeconomic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country-level data:
3.3 Assumptions and Limitations

4. North America Microelectrode Array in Vitro Market Landscape

4.1 PEST Analysis

5. North America Microelectrode Array in Vitro Market - Key Market Dynamics

5.1 Market Drivers
- 5.1.1 Increasing Demand for Microelectrode Arrays in Neuroscience Research
- 5.1.2 Rising Focus on Developing Alternatives for Animal Testing Models
5.2 Market Restraints
- 5.2.1 High Development Costs of Microelectrode Arrays
5.3 Market Opportunities
- 5.3.1 Microelectrode Arrays with Advanced Features
5.4 Future Trends
- 5.4.1 Integration of Microelectrode Array Technologies with Organ-On-A-Chip
5.5 Impact of Drivers and Restraints:

6. Microelectrode Array in Vitro Market - North America Analysis

6.1 North America Microelectrode Array in Vitro Market Revenue (US$ Thousand), 2021-2031
6.2 North America Microelectrode Array in Vitro Market Forecast Analysis

7. North America Microelectrode Array in Vitro Market Analysis - by Product

7.1 Classical MEA
- 7.1.1 Overview
- 7.1.2 Classical MEA: North America Microelectrode Array in Vitro Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
7.2 Multiwell-MEA
- 7.2.1 Overview
- 7.2.2 Multiwell-MEA: North America Microelectrode Array in Vitro Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
7.3 CMOS-MEA
- 7.3.1 Overview
- 7.3.2 CMOS-MEA: North America Microelectrode Array in Vitro Market - Revenue and Forecast, 2021-2031 (US$ Thousand)

8. North America Microelectrode Array in Vitro Market Analysis - by Application

8.1 Cardiomyocytes
- 8.1.1 Overview
- 8.1.2 Cardiomyocytes: North America Microelectrode Array in Vitro Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
8.2 Nerve
- 8.2.1 Overview
- 8.2.2 Nerve: North America Microelectrode Array in Vitro Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
8.3 Others
- 8.3.1 Overview
- 8.3.2 Others: North America Microelectrode Array in Vitro Market - Revenue and Forecast, 2021-2031 (US$ Thousand)

9. North America Microelectrode Array in Vitro Market - Country Analysis

9.1 North America
- 9.1.1 North America Microelectrode Array in Vitro Market - Revenue and Forecast Analysis - by Country
  - 9.1.1.1 North America Microelectrode Array in Vitro Market - Revenue and Forecast Analysis - by Country
  - 9.1.1.2 United States: North America Microelectrode Array in Vitro Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
    - 9.1.1.2.1 United States: North America Microelectrode Array in Vitro Market Share - by Product
    - 9.1.1.2.2 United States: North America Microelectrode Array in Vitro Market Share - by Application
  - 9.1.1.3 Canada: North America Microelectrode Array in Vitro Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
    - 9.1.1.3.1 Canada: North America Microelectrode Array in Vitro Market Share - by Product
    - 9.1.1.3.2 Canada: North America Microelectrode Array in Vitro Market Share - by Application
  - 9.1.1.4 Mexico: North America Microelectrode Array in Vitro Market - Revenue and Forecast, 2021-2031 (US$ Thousand)
    - 9.1.1.4.1 Mexico: North America Microelectrode Array in Vitro Market Share - by Product
    - 9.1.1.4.2 Mexico: North America Microelectrode Array in Vitro Market Share - by Application

10. Microelectrode Array in Vitro Market - Industry Landscape

10.1 Overview

11. Company Profiles

11.1 Tucker Davis Technologies
- 11.1.1 Key Facts
- 11.1.2 Business Description
- 11.1.3 Products and Services
- 11.1.4 Financial Overview
- 11.1.5 SWOT Analysis
- 11.1.6 Key Developments
11.2 SCREEN Holdings Co., Ltd.
- 11.2.1 Key Facts
- 11.2.2 Business Description
- 11.2.3 Products and Services
- 11.2.4 Financial Overview
- 11.2.5 SWOT Analysis
- 11.2.6 Key Developments
11.3 Plexon Inc.
- 11.3.1 Key Facts
- 11.3.2 Business Description
- 11.3.3 Products and Services
- 11.3.4 Financial Overview
- 11.3.5 SWOT Analysis
- 11.3.6 Key Developments
11.4 MaxWell Biosystems AG
- 11.4.1 Key Facts
- 11.4.2 Business Description
- 11.4.3 Products and Services
- 11.4.4 Financial Overview
- 11.4.5 SWOT Analysis
- 11.4.6 Key Developments
11.5 Harvard Bioscience Inc.
- 11.5.1 Key Facts
- 11.5.2 Business Description
- 11.5.3 Products and Services
- 11.5.4 Financial Overview
- 11.5.5 SWOT Analysis
- 11.5.6 Key Developments
11.6 Axion BioSystems Inc
- 11.6.1 Key Facts
- 11.6.2 Business Description
- 11.6.3 Products and Services
- 11.6.4 Financial Overview
- 11.6.5 SWOT Analysis
- 11.6.6 Key Developments
11.7 3Brain AG
- 11.7.1 Key Facts
- 11.7.2 Business Description
- 11.7.3 Products and Services
- 11.7.4 Financial Overview
- 11.7.5 SWOT Analysis
- 11.7.6 Key Developments
11.8 NeuroNexus Technologies Inc.
- 11.8.1 Key Facts
- 11.8.2 Business Description
- 11.8.3 Products and Services
- 11.8.4 Financial Overview
- 11.8.5 SWOT Analysis
- 11.8.6 Key Developments
11.9 MicroElectrodeDevices
- 11.9.1 Key Facts
- 11.9.2 Business Description
- 11.9.3 Products and Services
- 11.9.4 Financial Overview
- 11.9.5 SWOT Analysis
- 11.9.6 Key Developments
11.10 Blackrock Microsystems, Inc.
- 11.10.1 Key Facts
- 11.10.2 Business Description
- 11.10.3 Products and Services
- 11.10.4 Financial Overview
- 11.10.5 SWOT Analysis
- 11.10.6 Key Developments
11.11 NMI Technologietransfer GmbH
- 11.11.1 Key Facts
- 11.11.2 Business Description
- 11.11.3 Products and Services
- 11.11.4 Financial Overview
- 11.11.5 SWOT Analysis
- 11.11.6 Key Developments
11.12 BMSEED
- 11.12.1 Key Facts
- 11.12.2 Business Description
- 11.12.3 Products and Services
- 11.12.4 Financial Overview
- 11.12.5 SWOT Analysis
- 11.12.6 Key Developments

12. Appendix

12.1 Glossary of Terms
12.2 About The Insight Partners